Total Funding
7
Total FundingSeries B raised
Growth Score
pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
714911
Rempex Pharmaceuticals engages in the discovery and development of antibacterial drugs for antibiotic resistance.
Daniel D. Burgess: President & CEOPast Role: Hollis-Eden Pharmaceuticals, Chief Operating Officer & Chief Financial Officer
Elizabeth Morgan: Vice President of Clinical OperationsPast Role: Advanced Tissue Sciences, Executive Positions
About the Company
Rempex Pharmaceuticals, Inc. is a San Diego-based pharmaceutical company focused on the discovery and development of new antibacterial drugs to meet the growing clinical need created by multi-drug resistant bacterial pathogens.
The company’s internal development pipeline focuses on combining proprietary formulations, PK/PD strategies and
novel potentiating agents with proven antibiotics to overcome or directly inhibit the molecular mechanisms in bacteria responsible for antibiotic resistance.
